Other Vaccines - United Kingdom

United Kingdom

Highlights

The United Kingdom's Other Vaccines market is estimated to witness a significant growth in revenue, projected to reach US$1.47bn in 2024.
Moreover, it is expected to display a strong compound annual growth rate (CAGR 2024-2029) of 11.24%, leading to a market volume of US$2.50bn by 2029.
When compared globally, United States is anticipated to generate the highest revenue, amounting to US$24.73bn in 2024.
The United Kingdom is experiencing an increasing demand for other vaccines, driven by a growing awareness of the importance of preventive healthcare.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Other Vaccines market in United Kingdom is a rapidly growing market due to various factors that have led to an increase in demand for these vaccines.

Customer preferences: Customers in the United Kingdom are increasingly becoming aware of the importance of vaccination in preventing diseases. This has led to an increase in demand for Other Vaccines, which are used to prevent diseases other than the common ones like measles, mumps, and rubella.

Trends in the market: One of the major trends in the Other Vaccines market in United Kingdom is the increasing demand for vaccines that prevent diseases like HPV, meningitis, and pneumonia. This is due to the fact that these diseases have become more prevalent in recent years and customers are looking for ways to protect themselves and their families.Another trend in the market is the increasing availability of vaccines in pharmacies and clinics. This has made it easier for customers to access vaccines and has led to an increase in vaccination rates.

Local special circumstances: The United Kingdom has a comprehensive vaccination program that covers a wide range of diseases. However, there are certain groups of people who are at higher risk of contracting certain diseases and may require additional vaccines. For example, healthcare workers, travelers, and people with certain medical conditions may require additional vaccines to protect themselves.

Underlying macroeconomic factors: The United Kingdom has a strong healthcare system that is able to support the demand for vaccines. Additionally, the government provides funding for vaccines through the National Health Service (NHS), which ensures that vaccines are accessible to everyone.Overall, the Other Vaccines market in United Kingdom is expected to continue growing as customers become more aware of the importance of vaccination in preventing diseases. The increasing availability of vaccines and the strong healthcare system in the country are likely to support this growth.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.